C25
Conditions
Interventions
Group 1: A total of approximately 100 patients with suspected pancreatic cavity involvement will be included using bolus tracking with individualized trigger delay. The quality of contrast and assessm
suitably matched) with fixed trigger delay.
There will be no follow-up
CT acquisition will occur in routine clinical practice.
Group 2: historical control group as an additional arm to compare the new method of individual trigger delay.
Sponsors
LMU Klinikum der Universität München
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Indication for performing CTA of the pancreas. Age-adjusted normal serum creatinine or creatinine clearance > 30 ml / min / 1.73 m2 for safe contrast administration
Exclusion criteria
Exclusion criteria: Contraindication to the performance of computed tomography
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of contrast of the pancreas (1/2/3/4/5) | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of the delineability of pancreatic malignant space-occupying lesions in a cohort with patient-specific trigger delay compared with a historical collective with fixed trigger delay for bolus-tracking contrast. | — |
Countries
Germany
Contacts
Public ContactBastian Sabel
Klinik und Poliklinik für Radiologie
Outcome results
None listed